Results 21 to 30 of about 130,335 (313)

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review

open access: yesBMJ Open, 2023
Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF). Several factors may cause OAC switching.Objectives To examine the phenomenon of OAC switching in patients with AF, including all available evidence ...
Mary A De Vera   +4 more
doaj   +1 more source

Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward

open access: yesBMJ Global Health, 2020
Introduction Access to quality-assured medicines is an essential prerequisite for universal health coverage, and pharmaceutical distributors play an important role to assure the quality of medicines along the supply chain.Methods We retrospectively ...
Raffaella Ravinetto   +6 more
doaj   +1 more source

The reason for having a code of pharmaceutical ethics: Spanish Pharmacists Code of Ethics [PDF]

open access: yesFarmacia Hospitalaria, 2017
The pharmacist profession needs its own code of conduct set out in writing to serve as a stimulus to pharmacists in their day-to-day work in the different areas of pharmacy, in conjunction always with each individual pharmacist´s personal commitment ...
Ana Mulet Alberola   +3 more
doaj   +1 more source

Post-streptokinase PCI in STEMI patients exceeding the 24-h guidelines

open access: yesBeni-Suef University Journal of Basic and Applied Sciences, 2021
Background Due to delay in obtaining approval from insurance institution, performing PCI after successful reperfusion using streptokinase was postponed for ˃24 h-1 week.
El-Zahraa M. Esmat Sultan   +2 more
doaj   +1 more source

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Background Previous trials showed that antiangiogenesis or anti-programmed death protein 1/programmed death ligand 1 (PD-1/PD-L1) monotherapy only showed marginal effect in triple-negative breast cancer (TNBC).
Qiang Liu   +11 more
doaj   +1 more source

DRUG UTILIZATION REVIEW OF FLUOROQUINOLONES AMONG THE OUT-PATIENTS IN A PUBLIC SECTOR HOSPITAL, PAKISTAN

open access: yesInternational Journal of Pharmacy & Integrated Health Sciences, 2023
Background: The increase in antibiotic resistance is a challenging threat to the healthcare system. Irrational drug use, polypharmacy and the current epidemic of bacterial resistance is attributed to the over use of anti-microbial drugs. Objectives: The
Awais Arshaad   +6 more
doaj   +1 more source

Enhancement of Solubility and Improvement of Dissolution Rate of Atorvastatin Calcium Prepared as Nanosuspension

open access: yesIraqi Journal of Pharmaceutical Sciences, 2019
Atorvastatin have problem of very slightly aqueous solubility (0.1-1 mg/ml). Nano-suspension is used to enhance it’s of solubility and dissolution profile.
Ahmed H. Ali, Shaimaa N. Abd-Alhammid
doaj   +1 more source

PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Background Overexpression of programmed cell death protein 1 (PD-1) is linked to CD8+ T cell dysfunction and contributes to tumor immune escape. However, the prevalence and functional regulations of PD-1 expression on CD8+ T cells in human gastric cancer
Ying Wang   +13 more
doaj   +1 more source

A case report and literature review of olanzapine-associated hyperglycemia with previous history of gestational diabetes [PDF]

open access: yesMental Health Clinician, 2022
Background: Olanzapine (Zyprexa) package labeling includes a warning for hyperglycemia, stating physicians should consider the risks and benefits when prescribing olanzapine to patients with an established diagnosis of diabetes mellitus or having ...
Jennifer N. Alastanos, PharmD, BCPP, BCPS   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy